Cargando…
hUC-MSCs Attenuate Acute Graft-Versus-Host Disease through Chi3l1 Repression of Th17 Differentiation
Mesenchymal stem cells (MSCs) have already demonstrated definitive evidence of their clinical benefits in acute graft-versus-host disease (aGvHD) and other inflammatory diseases. However, the comprehensive mechanism of MSCs' immunomodulation properties has not been elucidated. To reveal their p...
Autores principales: | Liu, Weijiang, Yuan, Fulin, Bai, Haitao, Liu, Yuanlin, Li, Xue, Wang, Yang, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582900/ https://www.ncbi.nlm.nih.gov/pubmed/36277038 http://dx.doi.org/10.1155/2022/1052166 |
Ejemplares similares
-
The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2023) -
Efficient expansion and delayed senescence of hUC-MSCs by microcarrier–bioreactor system
por: Wang, Xia, et al.
Publicado: (2023) -
Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease
por: Zhao, Qinjun, et al.
Publicado: (2019) -
Resveratrol Exerts Dosage-Dependent Effects on the Self-Renewal and Neural Differentiation of hUC-MSCs
por: Wang, Xinxin, et al.
Publicado: (2016) -
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
por: Lu, Zhengjuan, et al.
Publicado: (2020)